BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8427394)

  • 1. A community-based trial of ivermectin for onchocerciasis control in the forest of southwestern Cameroon: clinical and parasitologic findings after three treatments.
    Somo RM; Ngosso A; Dinga JS; Enyong PA; Fobi G
    Am J Trop Med Hyg; 1993 Jan; 48(1):9-13. PubMed ID: 8427394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of onchocerciasis with severe skin and eye lesions in a hyperendemic zone in the forest of southwestern Cameroon: clinical, parasitologic, and entomologic findings.
    Somo RM; Enyong PA; Fobi G; Dinga JS; Lafleur C; Agnamey P; Ngosso A; Ngolle EM
    Am J Trop Med Hyg; 1993 Jan; 48(1):14-9. PubMed ID: 8427383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment.
    Wanji S; Kengne-Ouafo JA; Esum ME; Chounna PW; Tendongfor N; Adzemye BF; Eyong JE; Jato I; Datchoua-Poutcheu FR; Kah E; Enyong P; Taylor DW
    Parasit Vectors; 2015 Apr; 8():202. PubMed ID: 25886166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon.
    Katabarwa MN; Eyamba A; Nwane P; Enyong P; Yaya S; Baldiagaï J; Madi TK; Yougouda A; Andze GO; Richards FO
    Am J Trop Med Hyg; 2011 Dec; 85(6):1041-9. PubMed ID: 22144441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities.
    Collins RC; Gonzales-Peralta C; Castro J; Zea-Flores G; Cupp MS; Richards FO; Cupp EW
    Am J Trop Med Hyg; 1992 Aug; 47(2):156-69. PubMed ID: 1503185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon.
    Wanji S; Kengne-Ouafo JA; Esum ME; Chounna PW; Adzemye BF; Eyong JE; Jato I; Datchoua-Poutcheu FR; Abong RA; Enyong P; Taylor DW
    Parasit Vectors; 2015 Dec; 8():667. PubMed ID: 26715524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parasitological efficacy of repeated treatments with ivermectin in an onchocerciasis focus in north Cameroon].
    Boussinesq M; Chippaux JP; Ernould JC; Prod'Hon J; Quillévéré D
    Bull Soc Pathol Exot; 1993; 86(2):112-5. PubMed ID: 8353468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular and systemic side effects following ivermectin treatment in onchocerciasis patients from Sierra Leone.
    Stilma JS; Rothova A; van der Lelij G; Wilson WR; Barbe RF
    Acta Leiden; 1990; 59(1-2):207-10. PubMed ID: 2378206
    [No Abstract]   [Full Text] [Related]  

  • 9. Large scale ivermectin distribution and its epidemiological consequences.
    Remme J; De Sole G; Dadzie KY; Alley ES; Baker RH; Habbema JD; Plaisier AP; van Oortmarssen GJ; Samba EM
    Acta Leiden; 1990; 59(1-2):177-91. PubMed ID: 2198750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
    Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
    Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.
    Boussinesq M; Chippaux JP; Ernould JC; Quillevere D; Prod'hon J
    Am J Trop Med Hyg; 1995 Jul; 53(1):63-7. PubMed ID: 7625535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
    Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
    Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parasitological and clinical characterization of Simulium neavei-transmitted onchocerciasis in western Uganda.
    Fischer P; Kipp W; Bamuhiga J; Binta-Kahwa J; Kiefer A; Büttner DW
    Trop Med Parasitol; 1993 Dec; 44(4):311-21. PubMed ID: 8134773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to four doses given at six-monthly intervals.
    Whitworth JA; Morgan D; Maude GH; Luty AJ; Taylor DW
    Trans R Soc Trop Med Hyg; 1992; 86(3):277-80. PubMed ID: 1412652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field-Based Evidence of Single and Few Doses of Annual Ivermectin Treatment Efficacy in Eliminating Skin Microfilaria Load after a Decade of Intervention.
    Osue HO
    Ethiop J Health Sci; 2017 Mar; 27(2):129-138. PubMed ID: 28579708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Important progress towards elimination of onchocerciasis in the West Region of Cameroon.
    Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
    Parasit Vectors; 2017 Aug; 10(1):373. PubMed ID: 28774318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment.
    Awadzi K; Opoku NO; Attah SK; Addy ET; Duke BO; Nyame PK; Kshirsagar NA
    Ann Trop Med Parasitol; 1997 Apr; 91(3):281-96. PubMed ID: 9229021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to the initial dose.
    Whitworth JA; Morgan D; Maude GH; Downham MD; Taylor DW
    Trans R Soc Trop Med Hyg; 1991; 85(1):92-6. PubMed ID: 2068774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based treatment of onchocerciasis with ivermectin: acceptability and early adverse reactions.
    Pacque MC; Dukuly Z; Greene BM; Munoz B; Keyvan-Larijani E; Williams PN; Taylor HR
    Bull World Health Organ; 1989; 67(6):721-30. PubMed ID: 2633887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
    Awadzi K; Addy ET; Opoku NO; Plenge-Bönig A; Büttner DW
    Trop Med Parasitol; 1995 Dec; 46(4):213-20. PubMed ID: 8826100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.